Search research articles
Contact Us
Filters
Showing results (91-100 of 426) with videos related to
Page
of 43
Sort By:
Biofactors (Oxford, England)
|
April 11, 2012
Endothelial progenitor cells in diabetes mellitus
Lisa Menegazzo, Mattia Albiero, Angelo Avogaro, et al.
European Heart Journal
|
March 23, 2021
Where diabetes care meets cardiovascular research: our cardiovascular perspective at a Centre devoted to diabetes research and care
Gian Paolo Fadini, Saula Vigili de Kreutzenberg, Angelo Avogaro
Atherosclerosis
|
July 4, 2007
The good and the bad in the link between insulin resistance and vascular calcification
Gian Paolo Fadini, Paolo Pauletto, Angelo Avogaro, et al.
Metabolic Syndrome and Related Disorders
|
February 3, 2009
Mechanisms and significance of progenitor cell reduction in the metabolic syndrome
Gian Paolo Fadini, Carlo Agostini, Elisa Boscaro, et al.
Diabetes Research and Clinical Practice
|
March 3, 2009
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia
Gian Paolo Fadini, Mauro Rigato, Antonio Tiengo, et al.
Expert Opinion on Therapeutic Targets
|
May 23, 2013
Non-glycemic effects of pioglitazone and incretin-based therapies
Manfredi Rizzo, Angelo Avogaro, Giuseppe Montalto, et al.
Atherosclerosis
|
June 4, 2016
Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry
Roberta Cappellari, Marianna D'Anna, Angelo Avogaro, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
May 24, 2008
The emerging role of endothelial progenitor cells in pulmonary hypertension and diffuse lung diseases
Gian Paolo Fadini, Marco Schiavon, Angelo Avogaro, et al.
Free Radical Biology & Medicine
|
January 15, 2008
Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid?
Angelo Avogaro, Saula Vigili de Kreutzenberg, Gian Paolo Fadini
Current Diabetes Reports
|
March 29, 2014
Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy
Angelo Avogaro, Saula Vigili de Kreutzenberg, Gian Paolo Fadini
Page
of 43
Search research articles
Search
Showing results (91-100 of 426) with videos related to
Sort By:
Page
of 43
Biofactors (Oxford, England)
|
April 11, 2012
Endothelial progenitor cells in diabetes mellitus
Lisa Menegazzo, Mattia Albiero, Angelo Avogaro, et al.
European Heart Journal
|
March 23, 2021
Where diabetes care meets cardiovascular research: our cardiovascular perspective at a Centre devoted to diabetes research and care
Gian Paolo Fadini, Saula Vigili de Kreutzenberg, Angelo Avogaro
Atherosclerosis
|
July 4, 2007
The good and the bad in the link between insulin resistance and vascular calcification
Gian Paolo Fadini, Paolo Pauletto, Angelo Avogaro, et al.
Metabolic Syndrome and Related Disorders
|
February 3, 2009
Mechanisms and significance of progenitor cell reduction in the metabolic syndrome
Gian Paolo Fadini, Carlo Agostini, Elisa Boscaro, et al.
Diabetes Research and Clinical Practice
|
March 3, 2009
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia
Gian Paolo Fadini, Mauro Rigato, Antonio Tiengo, et al.
Expert Opinion on Therapeutic Targets
|
May 23, 2013
Non-glycemic effects of pioglitazone and incretin-based therapies
Manfredi Rizzo, Angelo Avogaro, Giuseppe Montalto, et al.
Atherosclerosis
|
June 4, 2016
Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry
Roberta Cappellari, Marianna D'Anna, Angelo Avogaro, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
May 24, 2008
The emerging role of endothelial progenitor cells in pulmonary hypertension and diffuse lung diseases
Gian Paolo Fadini, Marco Schiavon, Angelo Avogaro, et al.
Free Radical Biology & Medicine
|
January 15, 2008
Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid?
Angelo Avogaro, Saula Vigili de Kreutzenberg, Gian Paolo Fadini
Current Diabetes Reports
|
March 29, 2014
Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy
Angelo Avogaro, Saula Vigili de Kreutzenberg, Gian Paolo Fadini
Page
of 43